New York Hospital Queens is seeking individuals to take part in a Phase 2 clinical research study of adults with active Crohn’s disease, a chronic gastrointestinal disease with no cure.
The OPERA study will evaluate the safety and tolerability of an investigational drug and its effects on the symptoms of Crohn’s disease.
Crohn’s disease can affect individuals at any age. The disease alternates between periods without symptoms and “flares,” when the disease is active. People with active Crohn’s disease experience a range of symptoms caused by inflammation of the intestines, including painful abdominal cramps, diarrhea, and rectal bleeding, which at times can be severe.
Individuals may be eligible to enroll in the study if they are between 18 and 75 years old, and have active Crohn’s disease. Those not eligible to participate are pregnant or breast-feeding, have short bowel syndrome due to multiple small bowel resections, or if a stoma is present.
To learn more about the study and to see if you qualify for enrollment, go to nyhq.org/CrohnsOperaStudy.